Bipolar affective disorder (BAD) is badly controlled by existing medications. Cannabis use in patients with BAD is often reported and some reports have suggested that it reduces the side effects of BAD such as manic episodes and depression. This paper looks at BAD patients and their use of cannabis can help these symptoms. This paper will also look at the neuropharmacological properties of cannabinoids and how they might have a therapeutic effect in treating BAD.
Here is the full scientific article if you wish to download it.
This study has shown that the cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) may have a hypnotic and antidepressant effect on patients with BAD. Synthetic cannabinoids such as nabilone and dronabinol containing THC and CBD can also have a sedative and anticonvulsant effect on patients with BAD. Cannabinoids as a medication for BAD is now being tested in controlled trials according to this study.
It has been said by patients with BAD that taking street drugs, such as amphetamines and cannabis, can control their symptoms better than those prescribed by psychiatrists. There is a good pharmacological reason in believing whey cannabis can be better than other medications and that is duly because of its anti inflammatory effect in animal cells.
It is suggested that it is now time to prescribe cannabinoids, in carefully managed trials, to patients with bipolar disorder that say their standard medications aren’t working. While the results are promising, there is still a lack of studies and knowledge on the cannabis plant for it to be considered a proper form of treatment.